Cargando…
Choosing The Right Animal Model for Renal Cancer Research()
The increase in the life expectancy of patients with renal cell carcinoma (RCC) in the last decade is due to changes that have occurred in the area of preclinical studies. Understanding cancer pathophysiology and the emergence of new therapeutic options, including immunotherapy, would not be possibl...
Autores principales: | Sobczuk, Paweł, Brodziak, Anna, Khan, Mohammed Imran, Chhabra, Stuti, Fiedorowicz, Michał, Wełniak-Kamińska, Marlena, Synoradzki, Kamil, Bartnik, Ewa, Cudnoch-Jędrzejewska, Agnieszka, Czarnecka, Anna M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036425/ https://www.ncbi.nlm.nih.gov/pubmed/32092671 http://dx.doi.org/10.1016/j.tranon.2020.100745 |
Ejemplares similares
-
Molecular Biology of Osteosarcoma
por: Czarnecka, Anna M., et al.
Publicado: (2020) -
Renal toxicity of targeted therapies for renal cell carcinoma in patients with normal and impaired kidney function
por: Mielczarek, Łukasz, et al.
Publicado: (2021) -
TP53 in Biology and Treatment of Osteosarcoma
por: Synoradzki, Kamil Jozef, et al.
Publicado: (2021) -
TP53-Deficient Angiosarcoma Expression Profiling in Rat Model
por: Smyczyńska, Urszula, et al.
Publicado: (2020) -
Metastatic Tumor Burden and Loci as Predictors of First Line Sunitinib Treatment Efficacy in Patients with Renal Cell Carcinoma
por: Czarnecka, Anna M., et al.
Publicado: (2019)